SquareMind raises $18 million to launch Swan skin-imaging robot
SquareMind raised $18 million, including previously undisclosed pre-Series A financing, to bring Swan to market.
Evidence notes
- Sonder Capital led the round, with Deeptech 2030 Fund, Bpifrance, Adamed Technology, Calm/Storm Ventures and Teampact Ventures participating.
- Swan is a robotic full-body dermoscopy system for standardized imaging, lesion mapping and AI-assisted longitudinal review.
Company context
SquareMind is a Paris-based medical robotics company developing Swan, a robotic full-body dermoscopy system for dermatology. Swan automates standardized skin imaging and pairs the scan workflow with AI software for lesion mapping, change detection and physician review.